AstraZeneca wins FDA Approval for Prostate Cancer and Reduces IBD Pipeline
Thursday, the FDA supported AstraZeneca and Merck’s Lynparza (olaparib) for the therapy of grown-ups with metastatic emasculation safe prostate malignant growth when utilized in mix with abiraterone and prednisone or…